CUSIP No. 444903108
|
1
|
Name of Reporting Person: Taube Hodson Stonex Partners LLP
I.R.S. Identification No. of above person (entities only): Not Applicable
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions):
(a) [ ]
(b) [X]
|
3
|
SEC Use Only
|
4
|
Citizenship or Place of Organization: England
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
Sole Voting Power: 10,237,263 shares
|
6
|
Shared Voting Power: -0-
|
|
7
|
Sole Dispositive Power: 10,237,263 shares
|
|
8
|
Shared Dispositive Power: -0-
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person: 10,237,263 shares
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions):[ ]
|
11
|
Percent of Class Represented by Amount in Row (9): 5.14%*
|
12
|
Type of Reporting Person: FI
|
(a)
|
Name of Issuer:
|
Human Genome Sciences, Inc.
|
(b)
|
Address of Issuer's Principal Executive Offices:
|
|
4200 Shady Grove Road Rockville Maryland 20850-7464
|
(a)
|
Name of Person Filing: Taube Hudson Stonex Partners LLP
|
(b)
|
Address of Principal Business Office
|
|
or, if none, Residence:
|
|
Cassini House 1st Floor 57-59 St. James’s Street London, SW1A 1LD England
|
(c)
|
Citizenship:
|
England
|
(d)
|
Title of Class of Securities:
|
Common Stock, par value $.01 per share
|
(e)
|
CUSIP Number: 444903108
|
(a) [ ]
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
(b) [ ]
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
(c) [ ]
|
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
|
(d) [ ]
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
(e) [ ]
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
(f) [ ]
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
(g) [ ]
|
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
(h) [ ]
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
(i) [ ]
|
A church plan that is excluded form the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
(j) [X]
|
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
|
(k) [ ]
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:
|
(a)
|
Amount beneficially owned: 10,237,263 shares
|
(b)
|
Percent of class:
|
5.14%
|
(c)
|
Number of shares as to which the person has:
|
|
(i)
|
sole power to vote or to direct the vote: 10,237,263 shares
|
|
(ii)
|
shared power to vote or to direct the vote: -0-
|
|
(iii)
|
sole power to dispose or to direct the disposition of: 10,237,263 shares
|
(iv)
|
shared power to dispose or to direct the disposition of: -0-
|
Item 5.
|
Ownership of Five Percent or Less of a Class
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
|
Item 8.
|
Identification and Classification of Members of the Group
|
Item 9.
|
Notice of Dissolution of Group
|
Item 10.
|
Certification
|
Date: March 12, 2012 | TAUBE HODSON STONEX PARTNERS LLP |
By: /s/Wayne Jacobs
|
|
|
Wayne Jacobs – Financial Controller
|